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Abstract 
From suckling up to slaughter, pigs experience frequently enteritis outbreaks caused by various 
pathogens, most of them from bacterial origin. Preliminary epidemiological studies have shown that 
Escherichia coli are the most often isolated bacteria during diarrhoeas. 
Quinolones and penicillins are the most frequently used treatments when colibacillosis is 
suspected. Many reports have shown these bacteria became frequently resistant when these 
antibiotics were massively used. Moreover, many cross resistances were demonstrated in these 
antibiotiC families, leading to a major zootechnical and zoonotic concern. 
However, some antibiotics, like colistin, are effective to treat swine enteritis while they are known to 
involve no or few resistance. 
This article discusses some trial results that illustrate the observation of particular mechanisms of 
resistance of colistin that make it less susceptible to antibiotic resistance. In an experiment on the 
efficacy and safety of colistin for the treatment of colibacillosis in weaned piglets in an infected 
environment, no resistant strain of E. coli against colistin were isolated on rectal swabs after the 
treatment. 
Colistin ts not only clinically effective alternatives to quinolones and penicillins for the treatment of 
swine colibacillosis but also its use does not involve any antibiotic resistance profile. Colistin is 
therefore of great interest to overcome the situation of antibioresistance currently established in the 
intensive swine production after a massive use of the more traditional antibiotics, ammostdes and 
macrolides, that can lead to a major risk for human health. 
Introduction 
From suckling up to slaughter, pigs experience frequently enteritis outbreaks caused by vanous 
pathogens, most of them from bacterial origin. Preliminary epidemiological studies have shown that 
Escherichia coli is the most often isolated bacteria dunng diarrhoeas 
If quinolones and penicillins are among the most frequently used treatments when colibacillosis is 
suspected, many reports have shown these bacteria became frequently resistant when these 
antibiotics were masstvely used. Moreover. many cross resistances were demonstrated in these 
antibiotic families, leading to a major zootechnical and zoonotic concern. 
However, some antibiotics, like colistin are effective to treat swme enteritis while they are known to 
involve no or few resistance. 
In an experiment on the efficacy and safety of colistin for the treatment of colibacillosis in weaned 
piglets in an infected environment. some bacteriologtcal analysts are conducted at the end of the 
clinical study to check the emergence of resistant strams of E. coli against colistin. 
Material and methods 
In a farm w1th history of post-weamng diarrhoea caused by E. colt, piglets weaned between 21 and 
28 days of age were randomly split into 2 groups. 
When at least 10% of the piglets showed sign of colibacillosis, they were treated (Table 1} through 
drinking water either wtth a placebo, either with COLIVE (Colistin, Ceva Sante Ammale, France) 
for 5 days 
All s1ck animals (having shown clinical signs of diarrhoea at the begtnning or dunng the 
experiment) were tdentifted . 
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Among different criteria to assess efficacy of COLlVEr®, some bacteriological analysis were 
performed on feces collected by rectal swab at the end of the trial (Day 6) on all animals identified 
as sick during the experiment : 
Isolation and identification of haemolytic E. coli strains, 
Antibiogram to evaluate E. coli resistance to colistin after treatment. 
Table 1: Protocol 
Group A Group B 
Treatment Placebo COLIVE-re> 
Daily dosage 0.5 ml/10 kg BW in 2 100,000 IU colistin/ kg 
regimen administrations BW in 2 administrations 
I (Volume equivalent to group B) 
Duration 5 days 5 days 
Monitored 1- Isolation and identification of haemolytic strains of E. coli 
parameters on 2- Test of sensitivity (antibiograms) 
Day 6 
Results 
Beside the clinical cure rate that was significantly higher in group B (1 ), the search of haemolytic 
strains of E. coli showed they had completely disappeared in group B while 47.7% of the E. coli 
strains ISOlated on animals of group B were haemolytic (Graph 1 ). 
100% of this haemolytic strains isolated in group A were the serotype K88. 
In addition, 100% of the E. coli strains isolated in both group and tested on antibiograms were all 
susceptible to colistin . 
Graph 1: Number of haemolytic E. coli strams (%)isolated at the end of the treatment (Day 6) 
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Discussion 
Th1s tnal showed not only the efficacy of collstm (COLIVE ) at the applied dose for the treatment 
of post-weamng cohbac1IIOs1s but also evaluated the nsk of development of E. coli res1stance to th1s 
antHnfecllve after treatment Its use did not mduce any ant1b1ot1c res1stance profile 
Th1s result confirms that the occurrence of resistance to colistin are very rare. as reported 1n 
vanous stud1es (2) 
Cohstm IS therefore of great Interest to overcome the Situation of ant1b1ores1stance currently 
established 1n mtens1ve swme production after a mass1ve use of more traditional ant1b1ot1cs (such 
as qutnolones and pen1c1111ns) that can lead to a maJor nsk for human health 
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